论文部分内容阅读
目的探讨尼莫地平联合立止血在高血压脑出血患者中的应用效果。方法选取高血压脑出血患者180例,随机分为对照组84例、观察组96例,使其有可比性。对照组患者给予常规治疗,观察组患者在对照组基础上给予尼莫地平联合立止血进行治疗。对两组患者日常生活自理能力进行评价,并记录两组患者经过治疗血肿体积、NIHSS评分以及并发症。结果经过治疗ADL评分明显优于对照组,血肿体积以及NIHSS评分明显低于对照组,并发症发生明显少于对照组。上述比较,差异有统计学意义(P<0.05)。结论尼莫地平及立止血联合应用治疗高血压脑出血具有安全、有效、易操作等优点。
Objective To investigate the effect of nimodipine combined with rhizoma in patients with hypertensive intracerebral hemorrhage. Methods 180 patients with hypertensive intracerebral hemorrhage were randomly divided into control group (84 cases) and observation group (96 cases), making it comparable. Patients in the control group were given routine treatment. Patients in the observation group were treated with nimodipine combined with rhizome blood on the basis of the control group. The self-care ability of daily living in two groups of patients was evaluated, and the volume of treated hematoma, NIHSS score and complications in both groups were recorded. Results After treatment, the ADL score was significantly better than that of the control group. The hematoma volume and NIHSS score were significantly lower than those of the control group. The incidence of complications was significantly less than that of the control group. The above comparison, the difference was statistically significant (P <0.05). Conclusion The combined application of nimodipine and clopidogrel for hypertensive intracerebral hemorrhage is safe, effective and easy to operate.